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Abstract
Genome-wide association study (GWAS) data on a disease are increasingly available from multiple related populations. In
this scenario, meta-analyses can improve power to detect homogeneous genetic associations, but if there exist ancestry-
specific effects, via interactions on genetic background or with a causal effect that co-varies with genetic background, then
these will typically be obscured. To address this issue, we have developed a robust statistical method for detecting
susceptibility gene-ancestry interactions in multi-cohort GWAS based on closely-related populations. We use the leading
principal components of the empirical genotype matrix to cluster individuals into ‘‘ancestry groups’’ and then look for
evidence of heterogeneous genetic associations with disease or other trait across these clusters. Robustness is improved
when there are multiple cohorts, as the signal from true gene-ancestry interactions can then be distinguished from gene-
collection artefacts by comparing the observed interaction effect sizes in collection groups relative to ancestry groups.
When applied to colorectal cancer, we identified a missense polymorphism in iron-absorption gene CYBRD1 that associated
with disease in individuals of English, but not Scottish, ancestry. The association replicated in two additional, independently-
collected data sets. Our method can be used to detect associations between genetic variants and disease that have been
obscured by population genetic heterogeneity. It can be readily extended to the identification of genetic interactions on
other covariates such as measured environmental exposures. We envisage our methodology being of particular interest to
researchers with existing GWAS data, as ancestry groups can be easily defined and thus tested for interactions.
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Introduction
Genome-wide association studies have had a marked impact on
our understanding of the contribution of common variants to
common disease [1,2]. The prevalence of common diseases often
varies across ethnic groups [3], and hence it is perhaps not too
surprising to observe systematic differences in marker effect sizes
for GWAS in more closely related populations [4–6]. A
fundamental difficulty in testing whether such differences arise
owing to chance, study design and execution, or true population-
specific effects, is that the sample collection label is typically
confounded with the interaction effect.
To circumvent these problems, we have developed a robust
statistical test for gene-ancestry interactions that makes use of
observed and measured relatedness between closely-related
populations. The method re-assigns individuals to new ancestry
groups by clustering in the space defined by the leading principal
components of the empirical genotype matrix [7–10] and then
tests for differences in disease association signal between these new
ancestry groups. We then compare this evidence with analogous
tests for disease association performed with the original collection
labels. When populations are closely related, we expect overlap
between the collections in the principal component space such that
the allocation of samples to ancestry groups differs from that of the
original collection labels. If heterogeneity is observed and is due to
genetic background (or a variable correlated with genetic
background), the effect size and signal of heterogeneity should
increase when individuals are re-grouped by relatedness, whereas
for collection artefacts the effect size and signal of heterogeneity
should decrease. Signals of genetic heterogeneity observed by
chance can be filtered out in a replication stage by repeated testing
in multiple independent sample sets, even if these lack the
necessary information for ancestry assignment.
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Since intra-study effect heterogeneity can obscure true associ-
ations between polymorphisms and disease, a potential benefit of
our approach is the un-masking of true associations that are
specific to ancestral groups or stronger in one group than another.
Although intra-study gene-gene interactions or gene-pathway
interactions have previously been analysed [11,12] no study has
previously addressed GWAS gene-ancestry interactions.
Results
Overview of the gene-ancestry interaction method
The method is summarised in Figure 1 and details are provided
in the Materials and methods section. In brief, the analysis pipeline
consists of an initial step where two or more GWAS have been
identified on the same disease or trait of interest across closely
related populations. SNPs are then identified which appear to
show an interaction on ancestry; by first clustering the combined
set of individuals into ancestry groups and then statistically testing
for evidence of an ancestry group interaction term of association
with the trait. SNPs identified as putative interaction markers are
then tested for strength of association for an interaction on the
original cohort groups. For true ancestry-interactions the effect
size should increase when clustering on ancestry rather than
cohort label. Markers are then filtered to take forward only those
showing largest difference. Markers for which the statistical
evidence of an interaction is overwhelming, or ones showing
milder evidence but with additional functional or biological
relevance linking the marker to the trait, are taken forward to a
Replication stage. In the replication stage it is valid to only
genotype the marker(s) of interest in individuals sampled from the
original population groups. In this situation you are not abel to
assign such replication individuals to ancestry groups, but the
population label can be used as a noise proxy without bias, but
with some loss in power. Below, we present our results for a
GWAS of colorectal cancer.
Application of the method to a GWAS of colorectal
cancer susceptibility
Discovery Stage. The discovery stage involves steps 1 to 5 in
Figure 1. To illustrate the method and test its effectiveness, we
initially analysed data from 13,690 individuals obtained from two
parallel colorectal cancer (CRC) GWAS studies performed in
England and Scotland. The data has previously been analysed and
reported using conventional GWAS methods without consider-
ation of ancestry specific effects [13–16]. In the original study
there were two ‘‘Phases’’ of data collection. In Phase 1 an initial
genome-wide scan in 3,831 individuals - 1,849 from England and
1,982 from Scotland - genotyped using the Illumina Hap550 or
equivalent array, followed by a more focussed Phase 2 whereby
40,892 SNPs showing the best evidence of association in Phase 1
were genotyped in an independent set of 9,859 individuals,
comprising 5,744 from England and 4,115 from Scotland. Since
both Phases 1 and 2 of the data were available to us from the
outset, we used both of these for the discovery stage of our analysis.
It is important to note that for most studies we envisage only
having available a single Phase of discovery data; in which case the
below would be modified accordingly.
We characterised genetic ancestry by performing a principal
component analysis (PCA) after filtering out SNPs in regions of
long-range linkage disequilibrium [17] and pruning remaining
markers using a short-range LD filter (see Materials and methods). In
Phase 1, only the first two principal components (PCs) provided a
significant measure of separation between the two groups collected
from England and Scotland (Figure 2) and we used these two
components to group individuals according to their empirical
relatedness using the k-means clustering algorithm [18]. We
assessed a range of k values by computing the Bayesian
Information Criterion (BIC) [19] for each. The optimised BIC
was with k = 2 and we refer to the resulting two clusters as the
English and the Scottish ‘‘ancestry groups’’, in contrast to the
original English and Scottish ‘‘collection groups’’ (Figure 2).
Clustering by ancestry resulted in 18.5% of individuals changing
label - that is, these individuals were originally registered in, say,
the Scottish collection group, but were assigned to the English
ancestry group after clustering, or vice versa (see Table S2).
We then looked for single marker-ancestry interactions genome-
wide by fitting the heterogeneous logistic model of association (that
is, detecting different genetic associations with disease for different
ancestry groups) and comparing the fit of this model to that of the
null model with the same genetic association across all clusters
(although allowing distinct intercept terms for each cluster). Since
the first principal genetic component used to characterise ancestry
was disease-associated, we included this together with gender as
main effect adjustment covariates in both the heterogeneous and
null models. To compare the model fits, we used the BIC which
adjusts the model fit for complexity. We calculated the difference
in BIC statistics between the null-BIC and heterogeneous-BIC
models and used this difference as a test statistic (denoted Tanc, see
Materials and methods).
We also performed an analogous scan for single marker-
collection interactions by using the original collection groups in
place of ancestry, ‘‘Path B’’ in Figure 1, thus computing a new set
of test statistics (denoted Tcoll ). Tcoll statistics are analogous to Tanc
statistics, but computed using models fitted within collection
groups rather than ancestry groups. True heterogeneity on genetic
background should result in an increased signal of interaction
association (that is, TancwTcoll ), whereas collection artefacts will
tend to have TcollwTanc. From this, we highlighted for each SNP
the difference Tanc{Tcoll , referred to as the ‘‘D-statistic’’(see
Materials and methods). We retained markers above the 1% D-
statistic significance threshold (Figure S3), estimated by simulation
under the null hypothesis of no disease association for any
individual (see Materials and methods). After imposing this filter,
4,445 out of 485,757 markers remained, consistent with the
number (4,857) expected by chance.
In our special case we also have discovery data on a second
Phase. We then made use of the Phase 2 data in our discovery
stage by performing the same heterogeneity analysis (steps 1 to 4 in
Figure 1) and looking for signals of heterogeneity consistent with
those observed in Phase 1. We found that 388 of the 4,445 markers
identified for Phase 1 had been genotyped in Phase 2 of the
original study. We followed the same procedure used in Phase 1 by
running smartpca on the combined Phase 2 English and Scottish
collections and observed similar separation of individuals of
English and Scottish collection (Figure S1). In addition we used the
Eigenvectors derived in the PCA of Phase 2 to compute
projections of the components in Phase 1, thus checking that the
components were representative of ancestry rather than a
collection artefact (Figure S2).
We grouped Phase 2 individuals into ancestry clusters using the
k-means clustering algorithm in the space defined by the top two
leading principal components. As for Phase 1 individuals, the
clustering with k~2 yielded the optimal BIC. This resulted in
21% of individuals changing label (Table S3). We then computed
Tanc, Tcoll and D-statistics (as for Phase 1) and selected markers
with D-statistics exceeding the 1% significance threshold (again,
estimated from null simulations). Three markers passed through
this filter. However, we observed consistent directions of effect
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across both Phases for only a single marker, rs10455 at the
CYBRD1 locus. At this marker we observed a genetic association
with CRC in individuals from the English ancestry group (Phase 1
OR=0.852, 95% CI= 0.736–0.986 p= 0.0321, 2-sided; Phase 2
OR=0.904, 95% CI= 0.834–0.979] p= 0.0066, 1-sided), but no
disease association for those in the Scottish ancestry group.
Although, statistically, the evidence for heterogeneity and an
English ancestry-specific disease association was mild and, indeed,
we would expect exactly one marker to pass through the filters by
chance, we proceeded with replication given the functional context
of rs10455. rs10455 is located within the last exon of an iron-
regulated gene, cytochrome B reductase 1, that is expressed in the
intestine and plays a key role in dietary iron absorption (Genome
Browser refSeq NM 001127383).
Replication stage. To ascertain independent evidence for
the rs10455 association, we undertook a targeted replication stage
in which we sought additional CRC case-control cohorts from
equivalent (English and/or Scottish) populations. We identified a
small Phase 3 multi-ethnic cohort (that is, mixture of English and
Scottish collected individuals) of 631 cases and 731 controls. We
did not have access to genome-wide genotype data and hence
ancestry clustering could not be performed. However, as stated
above, in the Replication step this is not prohibitive as the
population label can be used as a noisy proxy for ancestry without
biasing the result, albeit for a loss in power (see Text S1 and Tables
S5 and S6).
Testing Phase 3 for variation in association signal for rs10455,
using logistic regression, showed additional mild, but consistent
evidence of a protective effect in England-collected individuals
(OR=0.886, 95% CI= 0.749–1.05, one-sided p= 0.083) and no
evidence of association in the Scotland-collected Phase 3
individuals (OR=1.09, 95% CI= 0.95–1.26, one-sided
p= 0.899). Our power calculations (Table S5) suggested that the
evidence of association in individuals of English ancestry was
actually slightly stronger than expected under the evidence from
Phases 1 and 2 of a 20% switch rate when ancestry was assigned
and a true odds ratio of 0.9 (as estimated for rs10455 from the
Phase 2 data).
Given the support for rs10455 in Phase 3, we undertook a
further analysis and sought additional replication in a larger
independent cohort of 7,395 cases and 4,202 controls collected in
England (‘Phase 4’, Table S1). We supplemented Phase 4 with a
further 5,193 Wellcome Trust Case Control Consortium 2
(WTCCC2) control samples known to be predominantly of
English ancestry (2,692 from the 1958 British Birth Cohort and
2,501 from the UK National Blood Service, see Table S1 and Text
S2). This sample size provided 99% power to detect the rs10455
association at the P= 0.05 level (assuming a 20% switch rate and
the same OR). Given that we tested only a single marker, we need
no multiple correction adjustment to the p-value for this Phase.
We performed logistic regression analysis and confirmed associ-
ation between CRC and rs10455 (OR=0.933, 95% CI= 0.891–
0.978, one-sided p= 0.00191).
Taken together, our analyses provide consistent evidence that
variation at rs10455 (chr2:172,119,519 bases, NCBI Build 36), at
the CYBRD1 locus, associates with CRC risk in individuals of
Figure 1. Summary of the Methodology. Flow diagram showing methodological steps for testing for interactions when there are two
comparable sources of heterogeneity. There are two paths (A and B) in the work flow, one for each source. In our case path A corresponds to ancestry
and path B corresponds to collection. If there is only a single collection, path A can be followed with steps 1A, 2A, 3A, 5, and 6 (i.e. without
computation of D-Statistics). Tanc is the heterogeneity test statistic computed with the ancestry clustering and Tcoll is the heterogeneity test statistic
computed with the collection clustering as defined in the methods.
doi:10.1371/journal.pone.0048687.g001
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English ancestry, but not, at detectable levels, in those of Scottish
ancestry (Figure 3 and Table S4). In a meta-analysis of the English
samples from all Phases with adjustment for gender, we observed
OR=0.918 (95% CI 0.884–0.953) with one-side p~3:9|10{6.
This is likely to be an underestimate of the true signal due the
availability of English collection groups rather than ancestry
groups in Phases 3 and 4.
The role of CYBRD1 in iron absorption is of particular interest
given that many studies have investigated the link between dietary
iron intake and the risk of colorectal cancer. Although the
relationship is not fully understood, increased dietary iron intake
correlates with increased risk of colorectal tumours in several
populations [20–23]. CYBRD1 appears to bind quercetin which
has been posited as a chemopreventive agent for colorectal cancer
[24]. CYBRD1 SNP rs884409 (r2~0:06, D9=1.0 with rs10455)
has also been associated with serum ferritin levels [25] and
CYBRD1 is over-expressed in colorectal cancers [26]. Although
rs10455 was originally genotyped as a tagSNP, it lies within the
last exon of CYBRD1. This exon contains an alternative translation
termination signal and rs10455 lies downstream of this signal, such
that in one transcript it is a missense change, Ser266Asp. This
change is predicted to be non-damaging by SIFT and Polyphen.
Discussion
We have described a new method to detect interaction effects of
specific genotypes on genetic background. It can be used to detect
associations between genetic variants and disease that have been
masked by population genetic heterogeneity. Our method can be
extended easily to look for interactions on other covariates such as
treatment or measured environmental exposures. We envisage our
method being of particular interest to researchers with existing
GWAS data sets, as the ancestry exposure variable can be easily
defined and thus tested for interactions. Here we discuss particular
issues that may arise in applying the method (Figure 1) to other
study designs (for details of each step in the methodology see the
Materials and Methods section).
Single Collection
If only a single collection is available, the method can be applied
by clustering on ancestry and investigating evidence by inspection
of large Tanc statistics and determining significance via null
simulation; following only ‘‘Path A’’ of Figure 1 and steps 1, 2, 3,
5, 6. This will be at the expense of loss of power provided by the
D-statistic filter.
Non-overlapping Collections
In cases where there is near-complete confounding of collection
and ancestry, our method can still be used to detect evidence of
heterogeneity, but lacks the ability to distinguish whether the
source is artifactual or the result of a disease risk factor correlating
with ancestry. In such cases, evidence of heterogeneity would be
assessed as for the Single Collection case using Tanc statistics
(‘‘Path A’’ of Figure 1 excluding step 4). Null simulations could be
used to estimate thresholds for the T-statistics. If there are multiple
independent collections from the same populations then artifacts
can be ruled out by evidence of consistent results, and
conventional meta-analysis approaches for heterogeneous effects
could also be applied [27], although our approach should have
increased power over this if the collections contain samples of
mixed ancestry.
Figure 2. First PC versus Second PC in Phase 1. Individuals in Phase 1 plotted in the space defined by the first two PCs computed from the
genotype matrix. Individuals are coloured by their collection group and case-control status indicated by the plotting symbol. There is considerable
overlap between the collection groups.
doi:10.1371/journal.pone.0048687.g002
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In selecting candidates for targeted replication, we suggest that
both statistical evidence and functional context are considered. In
our case, the statistical evidence for rs10455 was consistent but
mild and indeed the marker may have been missed by a
conventional GWAS analysis even within an English ancestry
group. However, true interactions acting through say environ-
mental effects covarying with ancestry may well lead to identified
markers more closely related to disease mechanisms and hence
located in or nearby genes with function previously implicated in
disease processes, as was the case for CYBRD1 here. For targeted
replication where the ancestry (or original exposure) cannot be
used directly, power calculations can be performed to show what
level of evidence would be expected given a range of plausible
switch/error rates, thereby guiding the sample sizes expected to be
necessary. Details of power calculations are provided in the
supplementary methods and implementation is included in the
available R code.
It is important to note that statistical evidence of interaction of a
polymorphism with an exposure need not reflect a direct biological
interaction. Such evidence is also consistent for an interaction with
an unobserved environmental exposure correlated with ancestry.
For example, diet might correlate more strongly with ancestry
than with residential location. Markers showing evidence of
collection, but not ancestry, heterogeneity might also be of interest
and could reflect any differences in the way the data was
ascertained. This might result from technical artefacts or other
sources of heterogeneity, such as those introduced by different
ascertainment criteria.
Heterogeneity in ethnic origins or sample collection is usually
regarded as a problem in GWAS owing to the type I and II errors
that it can introduce into the analysis. We have shown, however,
that heterogeneity between related populations can be used to a
researchers’s advantage when there is interaction between
genotype and ethnicity, or a factor that co-varies with ethnicity.
For such variants, our method potentially provides a way of
identifying disease SNPs with relatively small effects that can be
assessed further in appropriate validation sample sets without
GWAS data or in other ways, such as functional evaluation. Such
considerations apply to our putative colorectal cancer SNP
rs10455 which demonstrated the potential of our technique for
identifying interactions and hence predisposition genes.
Our clustering step makes discrete allocations of samples to
clusters. It would be interesting to take into account the
uncertainty in cluster membership within the association model,
perhaps using a probabilistic clustering model, see for example
[28]. This would be an interesting extension of the method we
present and may further improve power to detect interactions.
Materials and Methods
Ethics Statement
The ethics board was the ‘‘Southampton and South-West
Hampshire Research Ethics Committee (A)MREC/
06\Q1702\99’’. The collection of blood samples and clinico-
pathological information from patients and controls was under-
taken with written informed consent and ethical review board
Figure 3. Summary of Association Evidence at rs10455. Forest plot of estimated effect sizes (with 95% confidence intervals). In Phases 1 and 2,
the effect size is estimated from a logistic regression adjusted for gender within the English (blue) and Scottish (red) ancestry groups. In Phases 3 and
4 the effect size is estimated from a logistic regression adjusted for gender within the replication collection groups. The use of collections reduces
power relative to what would be expected if ancestry groups were available. Finally we performed a meta-analysis combining all the individuals in
Phase 1 and 2 Ancestry groups and Phase 3 and Phase 4 (English only) collection groups together with the additional WTCCC2 controls (coloured
black and grey). The Odds Ratios are estimated from a logistic regression adjusted for gender.
doi:10.1371/journal.pone.0048687.g003
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approval in accordance with the tenets of the Declaration of
Helsinki.
The Colorectal Cancer Cohorts
Table S1 provides detail about each of the CRC cohorts
analysed in this paper. We have four phases of data; the first two
were used for candidate discovery and the second two for
replication.
Data used for Discovery. The discovery set of colorectal
cancer cases and controls was derived from two distinct and
independent collections, one based in Scotland only, and the other
from across the UK, but predominantly from England. For
convenience, we have analysed the Scottish collected Phase 1 in
parallel with the UK collected Phase 1, and done the same for
Phases 2.
Phase 1 samples (a total of 3592) were genotyped at
approximately 550,000 SNPs using the Illumina Hap550 or
Hap300/Hap240S arrays. Based on SNPs with the best evidence
of association (from the original GWAS [15]) in Scotland Phase 1
or UK Phase 1 or both (approximately equal number of SNPs in
each category), 40,892 SNPs were then typed in 9701 Phase 2
samples using a custom Illumina Infinium array.
Conventional GWAS data from these cohorts have been
reported previously [13–16,29–31].
Data used for Replication. Replication phase 3 consists of a
total of 1273 English collected individuals and 1622 Scottish
collected individuals [16]. Only a single marker (rs10455) was
genotyped based on our Phase 1 and Phase 2 analyses for gene-
ancestry interactions and thus collection label was used as a proxy
for ancestry.
Replication phase 4 consists of 7395 CRC cases and 4202
controls collected in solely in England and were genotyped at
rs10455 only. In addition to boost power, we supplemented this
phase with 5193 UK controls sampled as part of the Wellcome
Trust Case-Control Consortium 2 (WTCCC2).
Statistical Methods
The whole methodology is summarised by Figure 1. In this
section each step is described fully.
Step 1: Defining the Ancestry and Collection Exposure
Spaces. We performed a principal component analysis (PCA) to
summarize observed relatedness of individuals. We selected
markers for the PCA by first removing SNPs in regions of long-
range linkage disequilibrium [17] and then by pruning the
remaining markers to exclude markers short range LD (we used
the sliding window method implemented in plink [32] with an r2
threshold of 0.2, a window width of 50 markers and a slide of 5
markers). We used the first two principal components to describe
ancestry (in Phase 1 and 2 of our study) and checked they
described ancestry rather than collection artifacts by projecting the
components computed from Phase 2 samples in the Phase 1
samples. We observed similar separation of Scottish and UK
collected samples as expected; more generally reference popula-
tions can be used to check for collection artifacts. At this stage we
also note whether any of the principal components are significantly
associated with phenotype so they can be included as adjustment
variables in subsequent analyses.
The collection exposure is a one dimensional factor variable. It
is fixed and defined according to design of the study/studies.
Step 2: Clustering Individuals by Ancestry and by
Collection. We clustered individuals (in phase 1 and phase 2)
in the space defined by the first two principal genetic components
using the k-means algorithm [18]. We refer to these clusterings as
ancestry clusterings and used the Bayesian information criterion
(BIC) [19] to select the value of k, with the constraint that k§2.
More generally any partitioning clustering algorithm can be used
to cluster individuals in the space characterising genetic ancestry.
The collection clustering is defined by the collection factor
variable and hence no clustering algorithm is required. Individuals
of the same collection are clustered together with the number of
clusters equal to the number of collection groups in the data. In
our example there are two clusters, one containing individuals
collected in Scotland and the other containing individuals
collected predominantly in England.
In our analysis the number of principal components selected for
defining the ancestry clustering was guided by differences observed
between our collections. More generally, and if there is only a
single cohort, this can be done by model-based variable selection
such as the techniques implemented in R package clustvarsel. Other
model-based clustering algorithms might be more appropriate for
defining an ancestry clustering, particularly if the clusters are not
of equal volume and shape as was the case with our example. We
also note that the number of collection clusters need not be the
same as the number of ancestry clusters; for example, there may be
a single collection comprising multiple ancestry groups. Since the
BIC is used for comparing models in our definition of the T- and
D-Statistics (see Materials and methods), the number of clusters is
automatically accounted for by our statistics. If the number of
clusters is the same for both ancestry and collection groupings, it
allows comparisons to be made easily and the switch rate from
collection to ancestry can be determined, but this is not essential
for the method to be effective.
Step 3A: Fitting the Heterogeneous Model of
Association. To detect evidence of heterogeneous associations
we fitted a mixture model for genetic association with phenotype.
If multiple clusterings of the individuals in the space defining
relatedness (or any other known source of heterogeneity) are
considered then a mixture model is defined for each clustering (i.e.
one for the Collection clustering and one for the Ancestry
Clustering). For the general case, we let
N k be the number of clusters of individuals in the exposure/
ancestry space.
N n be the total number of individuals in the study.
N Y be the n vector of phenotypes (binary for disease case-
control studies).
N g be the n vector of genotypes (taking values 0,1,2 or missing).
N X be a matrix containing the exposure/ancestry variables. In
our case for the ancestry exposure, X has dimension n|2 and
contains the first and second principal genetic components for
the individuals. More generally X can contain p variables and
can also define a non-genetic exposure.
N A be a matrix containing main effect adjustment covariates for
all individuals. It has dimension n|s where s is the total
number of adjustment covariates and entries aij denote the
values of the jth covariate for the ith individual. In our
example, A has two columns; one containing the gender
indicator variable and the other the first principal genetic
component (i.e. the first column of X ).
N Z be an indicator matrix containing cluster membership
information. It is of dimension n|k and for each individual i,
the entries zim are binary and satisfy
Pk
m~1 zim~1 and
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zim~
1 if individual i belongs to cluster m
0 otherwise

The k cluster model of heterogeneous association is then
defined by the following generalised linear model:
h E(Yi)½ ~
Xs
j~1
ajaijz
Xk
m~1
(b0mzb
1
mgi)zim ð1Þ
The function h(:) is the link function, aj are adjustment
parameters, b0m are cluster specific intercept terms and b
1
m are the
cluster specific genetic effect parameters. When Y is a binary
phenotype, the link function is taken as the logit function and the
model is a logistic regression model. When Y is a quantitative
trait, the link function is typically the identity function and the
model is an ordinary linear regression model.
The cluster specific intercept terms b0m allow different clusters to
have different background disease rates, while the cluster specific
genetic effect terms b1m allows the marker being tested to have
different associations to phenotype in different clusters. The model
can be fitted to the data using the iterative re-weighted least
squares algorithm to obtain maximum likelihood parameter
estimates. Using these parameter estimates, we compute the log
likelihood of the data under the fitted model and use this to define
a measure of model fit. Since nested models with more parameters
will always be more likely, we penalise the log likelihood (or more
specifically minus twice the log likelihood) with a term that
increases with the total number of parameters (r) in the model. We
compute the BIC which has penalty rlogn. In this context r
increases by two for each additional cluster (one extra intercept
parameter and one extra genetic effect parameter). In the
subsequent work we use B½ck(X ) to denote the BIC score
computed for the clustering ck(X ) obtained by clustering
individuals into k groups using exposure/ancestry variables X .
Step 3B: Calculating T-statistics (Tanc and Tcoll). To
quantify evidence for the heterogeneous association we define the
T-statistic by taking the difference in BIC statistics computed for
the heterogeneous model and the null model of association thus
accounting for model complexity.
To specify the null model, we note the null hypothesis is one of
no interaction heterogeneity at the genetic marker. If this is true,
there are two possible scenarios;
(i) There is no genetic association with phenotype for any of the
individuals at the marker.
(ii) There is a homogeneous genetic association with phenotype
across all individuals at the marker.
In both of these instances it could also be there are different
background prevalences of the disease and/or differences in allele
frequency or linkage disequilibrium within different clusters of
individuals (independently of genotype). It is important to allow for
this in the specification of the null model to prevent within cluster
main effects from dominating differences observed in the multi-
cluster interaction model fit. Consequently the null model for the k
cluster alternative is
h(E(Yi))~b1giz
Xs
j~1
ajaijz
Xk
m~1
b0m
We compute the BIC statistic for the null model and use
B0[ck(X )] to denote this quantity. The k-cluster null model
contains k21 fewer parameters than the k-cluster heterogeneity
model. It allows for different background prevalences of the
disease within different clusters (i.e. the cluster specific intercept
terms) and includes the ‘no association for any individuals’
scenario as a special case (i.e. b1 =0). The distinction between
scenarios (i) and (ii) can be made via assessment of the null model
fit, however this is not our primary motivation. It is important to
note that since our null model is one of homogeneity with respect
to the genetic effect of a marker, our methods (by design) will not
identify markers which were found to be associated with
phenotype using homogeneous association testing techniques
unless there is a considerable difference in the strength of
associations between different clusters of individuals.
The test statistic (referred to as the T statistic) we use to assess
evidence of heterogeneity is the difference in BIC for the
heterogeneous and null models. If we are assessing the fit of a
heterogeneous model with k clusters, the test statistic is
Tck (X )~B0½ck(X ){B½ck(X )
When the BIC is used for model selection, typically the model
yielding the smallest BIC is selected, hence we might consider a
positive BIC difference to be strong evidence of interaction
heterogeneity. However, we use the difference in BIC as a test
statistic and set significance thresholds by estimating its distribu-
tion under the null hypothesis.
In our analysis we refer to the T statistic computed using the
ancestry clustering as Tanc and refer to the T statistic computed
using the collection clustering as Tcoll .
Step 4: Calculating D-statistics. We have developed a
statistical framework to compare two different exposure spaces
(Ancestry and Collection in our work). More generally, we use C
and C to denote two different clusterings of individuals in
exposure spaces, denoted X and X  respectively. In our case, X
represents ancestry and is defined by the first two principal genetic
components and C(X ) is the clustering of individuals in this space
using two clusters. X  is the binary one-dimensional space
indicating whether or not the individual was collected in England
and C(X ) is the deterministic clustering imposed by the
following indicator variable X  with entries
xi~
1 if individual i collected in England
0 otherwise

More generally, the exposure spaces X and X  can be of
different dimension and clusterings C and C can have different
values of k (in our case X is two dimensional and X  is one
dimensional and both C and C have k~2 clusters). When k is
the same for C and C, the degree of overlap between the
clusterings can be quantified by the proportion of individuals that
switch labels in one clustering with respect to the other. If one of
the clusterings reflects the true source of the heterogeneity better
than the other, then the increased error associated with the ‘worse’
clustering will lead to a weaker signal of interaction heterogeneity
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when our procedure is used. We quantify the difference in signal
by computing the difference in test statistics:
D(C,C)~TC(X ){TC(X)
We refer to D(C,C) as the difference statistic. Positive values of
the test statistic indicate that clustering C reflects the source of the
interaction heterogeneity best, whereas negative values indicate
that clustering C reflects the source of the interaction heteroge-
neity best. Given that one of the clusterings does reflect the true
source of interaction heterogeneity, the magnitude of the
difference in statistic will depend on the degree of overlap between
the two clusterings and the strength of the associations. Small
positive or negative difference statistics might reflect the fact that
neither of the clusterings reflects the source of heterogeneity and
indicate that evidence of interaction heterogeneity might have
occurred by chance (although if clusterings have a high degree of
overlap, difference statistics with small absolute values are likely to
occur). In our analysis, the D-statistic computed compares the
ancestry clustering with the collection clustering. Thus
D~Tanc{Tcoll
Step 5: Defining Significance Thresholds and Filtering
Markers using evidence of Heterogeneity. There is no
theoretical distribution for the D-Statistic, so we simulated null
data sets (i.e. genotypes not associated with phenotype) to estimate
the properties and quantiles of this distribution. Note that null
distributions can differ between data sets according to the number
of individuals in the data set, the number of clusters, and the
contribution of adjustment variables to the model fit. The null
hypothesis includes two scenarios. Firstly, no genetic association
with phenotype for any individuals, and secondly, a homogeneous
(non-zero) genetic association for all individuals. Since our method
is designed to be used with GWA data, we assume that the vast
majority of markers will fall into the first category. Consequently
we estimate the distribution of test statistics under the null
hypothesis assuming there is no genetic association with phenotype
for any individuals. GWA case-control data sets are ascertained
retrospectively, so we use a retrospective simulation technique i.e.
simulating genotypes conditional on phenotype. The phenotype
remains fixed (at the observed phenotype) for all simulations and
the adjustment variables are also fixed and included in all
interaction and null models. Since we assume there is no
association of genotype with phenotype, under the assumption of
Hardy-Weinberg equilibrium, the simulation of genotypes de-
pends on the MAF. We investigated a range of allele frequencies
from 0.05 to 0.5 by intervals of 0.05 and noted that the
distribution of D-statistics were independent of MAF. Conse-
quently to define a significance threshold for D-statistics we used
the 99th centile of the statistics after pooling the 10|10,000
simulations across all allele frequencies. If only a single clustering is
being tested for heterogeneity (and thus no difference statistics are
calculated), thresholds on T statistics can be computed for each of
the simulations instead.
A 99% one sided threshold for D-statistics is used to select
markers enriched for ancestry heterogeneity rather than collection
heterogeneity (i.e. exposure A relative to exposure B). To define a
threshold to select markers enriched for collection heterogeneity
(exposure B) the 1% centile could be chosen.
To identify candidate (interaction/heterogeneous) phenotype
associated markers we suggest selecting markers whose D-statistics
exceed the significance and then rank on the basis of the T statistic
(in our case the ancestry T statistic Tanc). If multiple phases of data
are available for these markers then these markers can be checked
for consistency across phases.
Step 6: Replication. Replication of candidate markers for
interaction heterogeneity requires analysis of an independently
collected data set, however it is important that the exposure(s) used
to perform the original analysis can be collected (or estimated via
an alternative, potentially surrogate source) and further more, that
individuals in the replication phase lie in the same region of
exposure space as the original data. Replication can also be
undertaken even if the primary (ancestry) exposure and thus
clustering cannot be computed directly provided a variable highly
correlated with the primary exposure can be collected. The power
to detect the interaction will be poorer (depending on the strength
of the correlation between the proxy and the primary exposure)
but power calculations can be undertaken to show the expected
power.
In our example, in the replication phases 3 and 4 ancestry
information was not available but we used geographical collection
location as a proxy for it. We performed power calculations to
show what we might expect to see given the expected error in
using geographical collection location rather than ancestry. Details
of our power calculations are documented in the Text S1 and can
be modified for other data sets and/or exposure spaces.
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principal component in Phase 2: Individuals in Phase 2 plotted in
the space defined by the first two principal components computed
from the genotype matrix. Individuals are coloured by their
collection group and case-control status indicated by the plotting
symbol.
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Figure S2 PCA Projection. Projection of Phase 1 genotypes
onto Eigen vectors (defining the principal components) in Phase 2:
Separation of the English and Scottish collected samples indicate
the components were representative of ancestry rather than a
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Figure S3 D-statistics. The distribution of the D-Statistics
computed for Phase 1. The 1% significance threshold is indicated
by the red dashed line.
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Table S3 Composition of the ancestral clusters for phase 2
individuals stratified by collection source and disease status.
(PDF)
Table S4 Summary of Evidence for CRC Association at rs10455
in English Collected/Ancestral Cohorts.
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the switch rate varies.
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